Chandrakanth Boddu, MBBS - Medicare Orthopaedic Surgery in Boston, MA

Chandrakanth Boddu, MBBS is a medicare enrolled "Orthopaedic Surgery" physician in Boston, Massachusetts. His current practice location is Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (617) 726-8523.

Chandrakanth Boddu is licensed to practice in Massachusetts (license number L-264855) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1477936615.

Contact Information

Chandrakanth Boddu, MBBS
Massachusetts General Hospital, 55 Fruit Street,
Boston, MA 02114
(617) 726-8523
Not Available



Physician's Profile

Full NameChandrakanth Boddu
GenderMale
SpecialityOrthopaedic Surgery
LocationMassachusetts General Hospital, Boston, Massachusetts
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1477936615
  • Provider Enumeration Date: 07/07/2015
  • Last Update Date: 07/07/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 4880943281
  • Enrollment ID: I20180817002302

Medical Identifiers

Medical identifiers for Chandrakanth Boddu such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1477936615NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207X00000XOrthopaedic Surgery L-264855 (Massachusetts)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Chandrakanth Boddu allows following entities to bill medicare on his behalf.
Entity NameCarolina Family Care Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1184655722
PECOS PAC ID: 4587557731
Enrollment ID: O20040203000627

News Archive

Phase III trial of brentuximab vedotin for post-transplant Hodgkin lymphoma initiated

Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of a phase III clinical trial of brentuximab vedotin (SGN-35) for post-transplant Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells.

Rutgers scientist receives 2009 Gruber International Research Award

For the first time, it now is possible for researchers to peer into those internal processes in a rodent brain. Eva Pastalkova, a post-doctoral researcher at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark and her advisor, Professor Gy-rgy Buzsaki, have developed a method for studying internally generated brain activity in rats.

Chantix for smoking cessation performs better than placebos

Six treatments for smoking cessation perform better than placebos - including varenicline (Chantix), recently approved for use in Canada - states a team of researchers from McGill University and the University of Montreal in an article published in Canadian Medical Association Journal.

Seattle Post-Intelligencer examines reactions of people who participated in Merck's canceled HIV vaccine

The Seattle Post-Intelligencer on Friday examined the reaction of volunteers in the Seattle arm of Merck's recently halted HIV vaccine trial. According to the Post-Intelligencer, participants who were interviewed on the condition of anonymity have voiced "decidedly mixed feelings" about participating in the trial because of safety concerns (Paulson, Seattle Post-Intelligencer, 11/9).

MedAware Systems introduces complete database of research on Alzheimer's disease and dementia

MedAware Systems, Inc. announced today it is launching the world's most comprehensive database of human clinical trials data on Dementia / Alzheimer's disease. The database currently contains over 5,000 studies on Dementia and related diseases with more than 30 million data points available for analysis.

Read more Medical News

› Verified 3 days ago

Entity NameChester Medical Group, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174753024
PECOS PAC ID: 5496891038
Enrollment ID: O20091012000495

News Archive

Phase III trial of brentuximab vedotin for post-transplant Hodgkin lymphoma initiated

Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of a phase III clinical trial of brentuximab vedotin (SGN-35) for post-transplant Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells.

Rutgers scientist receives 2009 Gruber International Research Award

For the first time, it now is possible for researchers to peer into those internal processes in a rodent brain. Eva Pastalkova, a post-doctoral researcher at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark and her advisor, Professor Gy-rgy Buzsaki, have developed a method for studying internally generated brain activity in rats.

Chantix for smoking cessation performs better than placebos

Six treatments for smoking cessation perform better than placebos - including varenicline (Chantix), recently approved for use in Canada - states a team of researchers from McGill University and the University of Montreal in an article published in Canadian Medical Association Journal.

Seattle Post-Intelligencer examines reactions of people who participated in Merck's canceled HIV vaccine

The Seattle Post-Intelligencer on Friday examined the reaction of volunteers in the Seattle arm of Merck's recently halted HIV vaccine trial. According to the Post-Intelligencer, participants who were interviewed on the condition of anonymity have voiced "decidedly mixed feelings" about participating in the trial because of safety concerns (Paulson, Seattle Post-Intelligencer, 11/9).

MedAware Systems introduces complete database of research on Alzheimer's disease and dementia

MedAware Systems, Inc. announced today it is launching the world's most comprehensive database of human clinical trials data on Dementia / Alzheimer's disease. The database currently contains over 5,000 studies on Dementia and related diseases with more than 30 million data points available for analysis.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Chandrakanth Boddu is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Chandrakanth Boddu, MBBS
Massachusetts General Hospital, 55 Fruit Street,
Boston, MA 02114

Ph: (617) 726-8523
Chandrakanth Boddu, MBBS
Massachusetts General Hospital, 55 Fruit Street,
Boston, MA 02114

Ph: (617) 726-8523

News Archive

Phase III trial of brentuximab vedotin for post-transplant Hodgkin lymphoma initiated

Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of a phase III clinical trial of brentuximab vedotin (SGN-35) for post-transplant Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells.

Rutgers scientist receives 2009 Gruber International Research Award

For the first time, it now is possible for researchers to peer into those internal processes in a rodent brain. Eva Pastalkova, a post-doctoral researcher at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark and her advisor, Professor Gy-rgy Buzsaki, have developed a method for studying internally generated brain activity in rats.

Chantix for smoking cessation performs better than placebos

Six treatments for smoking cessation perform better than placebos - including varenicline (Chantix), recently approved for use in Canada - states a team of researchers from McGill University and the University of Montreal in an article published in Canadian Medical Association Journal.

Seattle Post-Intelligencer examines reactions of people who participated in Merck's canceled HIV vaccine

The Seattle Post-Intelligencer on Friday examined the reaction of volunteers in the Seattle arm of Merck's recently halted HIV vaccine trial. According to the Post-Intelligencer, participants who were interviewed on the condition of anonymity have voiced "decidedly mixed feelings" about participating in the trial because of safety concerns (Paulson, Seattle Post-Intelligencer, 11/9).

MedAware Systems introduces complete database of research on Alzheimer's disease and dementia

MedAware Systems, Inc. announced today it is launching the world's most comprehensive database of human clinical trials data on Dementia / Alzheimer's disease. The database currently contains over 5,000 studies on Dementia and related diseases with more than 30 million data points available for analysis.

Read more News

› Verified 3 days ago


Orthopaedic Surgery Doctors in Boston, MA

Kiran J Agarwal-harding, MD
Orthopedic Surgery
Medicare: Medicare Enrolled
Practice Location: Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114
Phone: 617-726-2942    
Dr. Adam Stephen Olsen, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 75 Francis St, Boston, MA 02115
Phone: 617-732-5655    
Dr. Bertram Zarins, M.D.
Orthopedic Surgery
Medicare: Medicare Enrolled
Practice Location: 175 Cambridge St, Suite 400, Boston, MA 02114
Phone: 617-726-3421    Fax: 617-726-3438
Andrew P White, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 330 Brookline Ave, Stoneman 10, Boston, MA 02215
Phone: 617-667-3940    
Ruth A Delaney, MD
Orthopedic Surgery
Medicare: Not Enrolled in Medicare
Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114
Phone: 617-726-2800    
Michael Douglas Baratz, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 800 Washington St, Boston, MA 02111
Phone: 617-636-5000    Fax: 617-636-1465
Sarah Stelma,
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 800 Washington St, Tmc Box 306, Boston, MA 02111
Phone: 617-636-5172    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.